Tuesday, March 26, 2024 12:39:19 AM
BTW, why was the information about Zimmer acquisition of Centerpulse withheld from the 2014 IPO paperwork but not the 2007 paperwork for information on the Chairman Dr Link? Why was the fact that Dr Bal, only a board member at the time, was a surgeon designer for Zimmer not included in the 2014 IPO paperwork the way it was included about Dr Hofmann on the 2007 IPO paperwork?
Point 1: Sintx CEO Dr Bal has been a paid consultant for Zimmer (surgeon designer from 2002 - 2014+)
Dr. Bal has been performing hip and knee replacements for the past twenty years and usually performs between 150 and 400 knee replacements each year. (Bal Rep. at 2; Bal Dep. 27:8-13.) In addition, he has acted as a paid consultant for hip and knee device manufacturers, including for Defendant, and has assisted in the design of implant components. (Bal Rep. at 2, 30.)
Point 2: Controlled Opposition is a method to control/neutralize information; in this case negative.
Preempt or neutralize true but negative information by having it be disclosed or championed in a skewed/stigmatized manner by a person or group. The truth can be peppered with disinformation or the truth of the message can be neutralized by association due to the extreme, radical, or unpalatable positions held by the controlled entity (person or group) who is disclosing the information or is “championing” a position. The stigmatized or adulterated truth in turn steers people away from truthful information which would normally cause criticism or a serious backlash against the controlling party.
Point 3: Zimmer Biomet CEO David Dvorak, in 2016 and Sintx CEO Dr Bal join OREF at the same time. Thus some hobnobbing would ensue for however long the two were on the board of trustees for...at least the entire period when that testimony took place.
In addition, the trustees welcome to the board: Jeffrey S. Abrams, MD (Princeton, NJ); Christopher R. Adams, MD (Naples, FL); B. Sonny Bal, MD, JD, MBA (Columbia, MO); Paul C. Collins, MD (Boise, ID); David C. Dvorak, JD (Warsaw, IN); James R. Ficke, MD (Baltimore, MD); and Joshua J. Jacobs, MD (Chicago, IL).
Point 4: After Dr Bal and Mr Dvorak join OREF, a partnership between Zimmer Biomet and OREF began.
The partnership between Zimmer Biomet and OREF will increase the dollars that are available to orthopaedic investigators through OREF’s grant programs and will encourage other donors to support OREF’s mission.
This exciting new chapter in our relationship demonstrates Zimmer Biomet’s ongoing commitment to both OREF and the orthopaedic community,” said David G. Lewallen, MD, President of the OREF Board of Trustees.
Quote Sources:
https://casetext.com/case/zimmer-nexgen-knee-implant-prods-liab-litig-beverly-goldin-v-zimmer-inc
https://www.urbandictionary.com/define.php?term=Controlled%20opposition
https://web.archive.org/web/20240326041531/https://www.prweb.com/releases/orthopaedic_research_and_education_foundation_welcomes_new_board_and_committee_members/prweb13440909.htm
https://www.todaysmedicaldevelopments.com/news/zimmer-biomet-orthopedic-medical-device-research-10516/
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Extra information on the status of a Si3n4 based hip implant:
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
- SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 01:00:06 PM
- SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/23/2025 08:31:09 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • KGC • Mar 16, 2026 9:00 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
